Document is current
Any future updates will be listed below
-
Authors
McIntyre, Roger S. https://orcid.org/0000-0003-4733-2523
Jain, Rakesh https://orcid.org/0000-0003-2456-2609
-
Funding
Funding for this research was provided by:
Axsome Therapeutics., Inc.
- License Information
-
More Information
Article History
Accepted: 22 July 2024
First Online: 16 August 2024
Declarations
:
: Development of this review was funded by Axsome Therapeutics., Inc., the manufacturer of Auvelity<sup>®</sup> (dextromethorphan–bupropion). The sponsor was involved in the original conception of the study; however, the authors were responsible for the critical appraisal of the work and decision to submit the manuscript for publication.
: R. Jain received speakers’ fees from Alkermes, Corium, Intra-Cellular Therapies, Ironshore Pharmaceuticals, Lilly, Lundbeck, Merck, Neos Therapeutics, Otsuka, Pamlab, Pfizer, Shire, Sunovion, Takeda, and Tris Pharmaceuticals; consultant fees from AbbVie, Acadia, Adamas, Alfasigma, Cingulate Therapeutics, Eisai, Evidera, Impel, Janssen, Lilly, Lundbeck, Merck, Neos Therapeutics, Neurocrine Biosciences, Osmotica, Otsuka, Pamlab, Pfizer, Shire, Sunovion, Supernus, Takeda, and Teva; is an advisory board member for Adamas, Alkermes, Janssen, Lilly, Lundbeck, Merck, Neos Therapeutics, Neurocrine Biosciences, Otsuka, Pamlab, Pfizer, Shire, Sunovion, Supernus, Takeda, and Teva; and received research support from AbbVie, Lilly, Lundbeck, Otsuka, Pfizer, Shire, and Takeda. R. S. McIntyre has received research grant support from CIHR/GACD/National Natural Science Foundation of China (NSFC); and speaker/consultation fees from Lundbeck, Janssen, Alkermes, Neumora Therapeutics, Boehringer Ingelheim, Sage, Biogen, Mitsubishi Tanabe, Purdue, Pfizer, Otsuka, Takeda, Neurocrine, Sunovion, Bausch Health, Axsome, Novo Nordisk, Kris, Sanofi, Eisai, Intra-Cellular Therapies, Inc., NewBridge Pharmaceuticals, AbbVie, and Atai Life Sciences. He is CEO of Braxia Scientific Corp (a company focused on ketamine treatment and psychedelic medicine for advanced mental health treatments).
: Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Both authors contributed to the manuscript conception and design, read and critically reviewed and revised the work, approved the final submitted manuscript, and agree to be accountable for the work.
